2026 Q2 Portfolio Activity
In 2026 Q2, Nan Fung Group Holdings Ltd maintained a portfolio of 26 distinct positions. The most significant new addition was ASCENDIS PHARMA A/S, now representing 2.76% of the total fund value. They heavily accumulated shares in CYBIN INC, increasing the position by 114.6%. Conversely, Nan Fung Group Holdings Ltd completely exited their position in ASCENDIS PHARMA A/S.
Position History
hover any row below to update
Loading…
Total Positions
26
Quarter
2026 Q2
Top Holding
MPLT (26.5%)
Top 10 Concentration
82.4%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-26 of 26
Nan Fung Group Holdings Ltd Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 26.47% | 16.28% |
#1
1
Prev: #2
|
7.0 |
—
|
no change | no change |
P
S
|
971,253 | $34,809,708 |
$17.57
-31.2%
|
2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 15.57% | 12.82% |
#2
1
Prev: #3
|
6.5 |
—
|
no change | no change |
P
S
|
630,657 | $20,467,973 |
$20.44
+118.3%
|
2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
EVMN
EVOMMUNE INC
|
Healthcare | 14.56% | 27.32% |
#3
2
Prev: #1
|
6.0 |
—
|
no change | no change |
P
S
|
1,441,032 | $19,151,315 |
$17.12
nan%
|
2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
CYBN
CYBIN INC
|
Unknown | 4.96% | 1.82% |
#4
10
Prev: #14
|
5.5 |
—
|
527,222 | 114.6% |
P
S
|
987,222 | $6,525,537 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
INCY
INCYTE CORP
|
Healthcare | 4.63% | 4.17% |
#5
Prev: #5
|
3.4 |
—
|
no change | no change |
P
S
|
53,742 | $6,092,193 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 4.15% | 3.52% |
#6
1
Prev: #7
|
2.7 |
—
|
no change | no change |
P
S
|
49,120 | $5,453,794 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ONC
BEONE MEDICINES...
|
Healthcare | 3.41% | 3.85% |
#7
1
Prev: #6
|
2.4 |
—
|
no change | no change |
P
S
|
15,722 | $4,480,298 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
OCS
OCULIS HOLDING ...
|
Healthcare | 3.17% | 7.69% |
#8
4
Prev: #4
|
1.8 |
—
|
-50,180 | -14.3% |
P
S
|
300,565 | $4,168,837 | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
N/A
ASCENDIS PHARMA...
|
|
Unknown | 2.76% | — |
#9
Prev: #—
|
4.6 |
—
|
13,600 | — |
NEW
|
13,600 | $3,627,392 | — | 13F Filing | 2026-06-30 | 2026-08-13 | ||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 2.74% | 1.54% |
#10
6
Prev: #16
|
2.1 |
—
|
no change | no change |
P
S
|
19,253 | $3,605,702 | 2024 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 2.69% | 2.12% |
#11
1
Prev: #12
|
2.1 |
—
|
no change | no change |
P
S
|
30,875 | $3,540,436 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 2.32% | 2.45% |
#12
1
Prev: #11
|
1.9 |
—
|
no change | no change |
P
S
|
5,672 | $3,045,580 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CELC
CELCUITY INC
|
Healthcare | 2.25% | 2.66% |
#13
5
Prev: #8
|
1.9 |
—
|
no change | no change |
P
S
|
28,300 | $2,960,746 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 1.98% | 1.89% |
#14
1
Prev: #13
|
1.8 |
—
|
no change | no change |
P
S
|
102,984 | $2,605,495 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ARGX
ARGENX SE
|
Healthcare | 1.98% | 1.69% |
#15
Prev: #15
|
1.8 |
—
|
no change | no change |
P
S
|
2,800 | $2,597,756 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
RXRX
RECURSION PHARM...
|
Healthcare | 1.66% | 1.51% |
#16
1
Prev: #17
|
1.7 |
—
|
no change | no change |
P
S
|
595,287 | $2,184,703 | 2024 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
PCOR
PROCORE TECHNOL...
|
Technology | 1.65% | 2.51% |
#17
7
Prev: #10
|
1.7 |
—
|
no change | no change |
P
S
|
53,299 | $2,165,005 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 0.75% | 0.62% |
#18
2
Prev: #20
|
1.3 |
—
|
no change | no change |
P
S
|
27,049 | $984,854 | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
INSM
INSMED INC
|
Healthcare | 0.53% | 0.89% |
#19
1
Prev: #18
|
1.2 |
—
|
no change | no change |
P
S
|
6,580 | $701,560 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ETHA
ISHARES ETHEREU...
|
ETF | 0.46% | 0.66% |
#20
1
Prev: #19
|
1.2 |
—
|
no change | no change |
P
S
|
50,549 | $601,028 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
IBIT
ISHARES BITCOIN...
|
Bond/Debt | 0.40% | 0.51% |
#21
1
Prev: #22
|
1.2 |
—
|
no change | no change |
P
S
|
15,968 | $531,575 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
CHYM
CHIME FINL INC
|
Technology | 0.33% | — |
#22
Prev: #—
|
3.6 |
—
|
21,075 | — |
NEW
|
21,075 | $431,616 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
RANI
RANI THERAPEUTI...
|
Healthcare | 0.29% | 0.30% |
#23
Prev: #23
|
1.1 |
—
|
no change | no change |
P
S
|
493,584 | $375,321 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
TRDA
ENTRADA THERAPE...
|
Healthcare | 0.27% | 0.51% |
#24
3
Prev: #21
|
1.1 |
—
|
no change | no change |
P
S
|
49,082 | $361,244 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
BOLT
BOLT BIOTHERAPE...
|
Healthcare | 0.01% | 0.10% |
#25
1
Prev: #24
|
0.0 |
—
|
-24,250 | -82.9% |
P
S
|
5,000 | $19,250 | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-13 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 0.00% | 2.57% |
Sold All 😨
(Was: #9) |
0.0 |
—
|
-13,600 | -100.0% |
CLOSED
|
— | $— | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-13 |
Showing 1-26 of 26 holdings